PISCATAWAY, N.J. – Camber Pharmaceuticals is excited to expand its product line with avanafil tablets. A study by the Cleveland Clinic reveals that about 40% of men experience erectile dysfunction (ED) by age 40, with this number rising to nearly 70% by age 70.
Avanafil tablets is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.
Avanafil tablets are available in 50, 100 and 200 mg strengths in 30 count bottles.
To learn more about avanafil tablets, visit